Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys
- 27 May 2020
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 12 (545)
- https://doi.org/10.1126/scitranslmed.aay1359
Abstract
Effective delivery of protein therapeutics to the central nervous system (CNS) has been greatly restricted by the blood-brain barrier (BBB). We describe the development of a BBB transport vehicle (TV) comprising an engineered Fc fragment that exploits receptor-mediated transcytosis for CNS delivery of biotherapeutics by binding a highly expressed brain endothelial cell target. TVs were engineered using directed evolution to bind the apical domain of the human transferrin receptor (hTfR) without the use of amino acid insertions, deletions, or unnatural appendages. A crystal structure of the TV-TfR complex revealed the TV binding site to be away from transferrin and FcRn binding sites, which was further confirmed experimentally in vitro and in vivo. Recombinant expression of TVs fused to anti–β-secretase (BACE1) Fabs yielded antibody transport vehicle (ATV) molecules with native immunoglobulin G (IgG) structure and stability. Peripheral administration of anti-BACE1 ATVs to hTfR-engineered mice and cynomolgus monkeys resulted in substantially improved CNS uptake and sustained pharmacodynamic responses. The TV platform readily accommodates numerous additional configurations, including bispecific antibodies and protein fusions, yielding a highly modular CNS delivery platform.Keywords
This publication has 65 references indexed in Scilit:
- Open questions for Alzheimer’s disease immunotherapyAlzheimer's Research & Therapy, 2014
- A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in VivoScience Translational Medicine, 2011
- Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis TargetScience Translational Medicine, 2011
- Engaging neuroscience to advance translational research in brain barrier biologyNature Reviews Neuroscience, 2011
- Macromolecular drug transport into the brain using targeted therapyJournal of Neurochemistry, 2010
- An Overview of APP Processing Enzymes and ProductsNeuroMolecular Medicine, 2009
- Highly avid magnetic bead capture: An efficient selection method for de novo protein engineering utilizing yeast surface displayBiotechnology Progress, 2009
- Blood–Brain Barrier Transport of Therapeutics via Receptor-MediationPharmaceutical Research, 2007
- Endocytic recyclingNature Reviews Molecular Cell Biology, 2004
- Effector Function Activities of a Panel of Mutants of a Broadly Neutralizing Antibody against Human Immunodeficiency Virus Type 1Journal of Virology, 2001